Product References
GDF15 Is an Eribulin Response Biomarker also Required for Survival of DTP Breast Cancer Cells.
Cancers
Bellio C,Emperador M,Castellano P,Gris-Oliver A,Canals F,Sánchez-Pla A,Zamora E,Arribas J,Saura C,Serra V,Tabernero J,Littlefield BA,Villanueva J
Mon May 23 00:00:00 UTC 2022
Butyrate supplementation regulates expression of chromosome segregation 1‑like protein to reverse the genetic distortion caused by p53 mutations in colorectal cancer.
International journal of oncology
Chang CC,Kao WY,Liu CY,Su HH,Kan YA,Lin PY,Ku WC,Chang KW,Yang RN,Huang CJ
Wed Jun 01 00:00:00 UTC 2022
Butyrate supplementation regulates expression of chromosome segregation 1‑like protein to reverse the genetic distortion caused by p53 mutations in colorectal cancer.
International journal of oncology
Chang CC,Kao WY,Liu CY,Su HH,Kan YA,Lin PY,Ku WC,Chang KW,Yang RN,Huang CJ
Wed Jun 01 00:00:00 UTC 2022
Butyrate supplementation regulates expression of chromosome segregation 1‑like protein to reverse the genetic distortion caused by p53 mutations in colorectal cancer.
International journal of oncology
Chang CC,Kao WY,Liu CY,Su HH,Kan YA,Lin PY,Ku WC,Chang KW,Yang RN,Huang CJ
Wed Jun 01 00:00:00 UTC 2022
Butyrate supplementation regulates expression of chromosome segregation 1‑like protein to reverse the genetic distortion caused by p53 mutations in colorectal cancer.
International journal of oncology
Chang CC,Kao WY,Liu CY,Su HH,Kan YA,Lin PY,Ku WC,Chang KW,Yang RN,Huang CJ
Wed Jun 01 00:00:00 UTC 2022
Butyrate supplementation regulates expression of chromosome segregation 1‑like protein to reverse the genetic distortion caused by p53 mutations in colorectal cancer.
International journal of oncology
Chang CC,Kao WY,Liu CY,Su HH,Kan YA,Lin PY,Ku WC,Chang KW,Yang RN,Huang CJ
Wed Jun 01 00:00:00 UTC 2022
Butyrate supplementation regulates expression of chromosome segregation 1‑like protein to reverse the genetic distortion caused by p53 mutations in colorectal cancer.
International journal of oncology
Chang CC,Kao WY,Liu CY,Su HH,Kan YA,Lin PY,Ku WC,Chang KW,Yang RN,Huang CJ
Wed Jun 01 00:00:00 UTC 2022
CSE1L, as a novel prognostic marker, promotes pancreatic cancer proliferation by regulating the AKT/mTOR signaling pathway.
Journal of Cancer
Zhang X,Zhang X,Mao T,Xu H,Cui J,Lin H,Wang L
Fri Apr 16 00:00:00 UTC 2021
Efficient generation of isogenic primary human myeloid cells using CRISPR-Cas9 ribonucleoproteins.
Cell reports
Hiatt J,Cavero DA,McGregor MJ,Zheng W,Budzik JM,Roth TL,Haas KM,Wu D,Rathore U,Meyer-Franke A,Bouzidi MS,Shifrut E,Lee Y,Kumar VE,Dang EV,Gordon DE,Wojcechowskyj JA,Hultquist JF,Fontaine KA,Pillai SK,Cox JS,Ernst JD,Krogan NJ,Marson A
Tue May 11 00:00:00 UTC 2021
A protein-interaction network of interferon-stimulated genes extends the innate immune system landscape.
Nature immunology
Hubel P,Urban C,Bergant V,Schneider WM,Knauer B,Stukalov A,Scaturro P,Mann A,Brunotte L,Hoffmann HH,Schoggins JW,Schwemmle M,Mann M,Rice CM,Pichlmair A
Mon Apr 01 00:00:00 UTC 2019
RNA-binding proteins and heat-shock protein 90 are constituents of the cytoplasmic capping enzyme interactome.
The Journal of biological chemistry
Trotman JB,Agana BA,Giltmier AJ,Wysocki VH,Schoenberg DR
Fri Oct 26 00:00:00 UTC 2018
RNA-binding proteins and heat-shock protein 90 are constituents of the cytoplasmic capping enzyme interactome.
The Journal of biological chemistry
Trotman JB,Agana BA,Giltmier AJ,Wysocki VH,Schoenberg DR
Fri Oct 26 00:00:00 UTC 2018
Hydrogen sulfide facilities production of nitric oxide via the Akt/endothelial nitric oxide synthases signaling pathway to protect human umbilical vein endothelial cells from injury by angiotensin II.
Molecular medicine reports
Cui J,Zhuang S,Qi S,Li L,Zhou J,Zhang W,Zhao Y,Qi N,Yin Y,Huang L
Wed Nov 01 00:00:00 UTC 2017
Hydrogen sulfide facilities production of nitric oxide via the Akt/endothelial nitric oxide synthases signaling pathway to protect human umbilical vein endothelial cells from injury by angiotensin II.
Molecular medicine reports
Cui J,Zhuang S,Qi S,Li L,Zhou J,Zhang W,Zhao Y,Qi N,Yin Y,Huang L
Wed Nov 01 00:00:00 UTC 2017
CSE1L interaction with MSH6 promotes osteosarcoma progression and predicts poor patient survival.
Scientific reports
Cheng DD,Lin HC,Li SJ,Yao M,Yang QC,Fan CY
Fri Apr 07 00:00:00 UTC 2017
CSE1L interaction with MSH6 promotes osteosarcoma progression and predicts poor patient survival.
Scientific reports
Cheng DD,Lin HC,Li SJ,Yao M,Yang QC,Fan CY
Fri Apr 07 00:00:00 UTC 2017
CSE1L interaction with MSH6 promotes osteosarcoma progression and predicts poor patient survival.
Scientific reports
Cheng DD,Lin HC,Li SJ,Yao M,Yang QC,Fan CY
Fri Apr 07 00:00:00 UTC 2017
CSE1L interaction with MSH6 promotes osteosarcoma progression and predicts poor patient survival.
Scientific reports
Cheng DD,Lin HC,Li SJ,Yao M,Yang QC,Fan CY
Fri Apr 07 00:00:00 UTC 2017